J Vela-Ojeda
Overview
Explore the profile of J Vela-Ojeda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomez-Almaguer D, Vazquez-Mellado A, Navarro-Cabrera J, Abello-Polo V, Milovic V, Garcia J, et al.
Bone Marrow Transplant
. 2016 Aug;
52(1):41-46.
PMID: 27548465
We studied 298 patients with severe aplastic anaemia (SAA) allografted in four Latin American countries. The source of cells was bone marrow (BM) in 94 patients and PBSCs in 204...
2.
Mahindra A, Kalaycio M, Vela-Ojeda J, Vesole D, Zhang M, Li P, et al.
Leukemia
. 2011 Nov;
26(5):1091-7.
PMID: 22042147
There are limited data on hematopoietic cell transplantation (HCT) in primary plasma cell leukemia (pPCL), an aggressive plasma cell disorder. We report outcomes of 147 patients with pPCL receiving autologous...
3.
Hari P, Zhang M, Roy V, Perez W, Bashey A, To L, et al.
Leukemia
. 2009 Mar;
23(8):1528-34.
PMID: 19322205
The international staging system (ISS) for multiple myeloma (MM) is a validated alternative to the Durie-Salmon staging system (DSS) for predicting survival at diagnosis. We compared these staging systems for...
4.
Vela-Ojeda J, Garcia-Ruiz Esparza M, Padilla-Gonzalez Y, Sanchez-Cortes E, Garcia-Chavez J, Montiel-Cervantes L, et al.
Ann Hematol
. 2008 Jul;
88(1):59-66.
PMID: 18648809
Several prognostic factors have been recognized in patients with multiple myeloma (MM). Among the most important are: the serum levels of beta2-microglobulin, albumin, and LDH; the labeling index; and an...
5.
Vela-Ojeda J, Garcia-Ruiz-Esparza M, Padilla-Gonzalez Y, Gomez-Almaguer D, Gutierrez-Aguirre C, Gomez-Rangel D, et al.
Ann Hematol
. 2007 Jan;
86(4):277-82.
PMID: 17262193
Autologous peripheral blood stem cell transplantation is the therapy of choice for the treatment of multiple myeloma (MM) patients younger than 70 years old. Between August 1993 and November 2004,...
6.
Vela-Ojeda J, Garcia-Ruiz Esparza M, Reyes-Maldonado E, Jimenez-Zamudio L, Garcia-Latorre E, Moreno-Lafont M, et al.
Ann Hematol
. 2006 Mar;
85(5):308-14.
PMID: 16525786
Between June 2003 and November 2004, we collected mobilized peripheral blood units from 29 patients with non-Hodgkin's lymphoma and multiple myeloma for autologous peripheral blood stem cell transplantation. They received...
7.
Vela-Ojeda J, Garcia-Ruiz Esparza M, Reyes-Maldonado E, Jimenez-Zamudio L, Garcia-Latorre E, Moreno-Lafont M, et al.
Ann Hematol
. 2005 Nov;
85(2):113-20.
PMID: 16311734
To analyze the relationship between the cellular composition of peripheral blood allografts and clinical outcome, we performed a prospective study in 45 adult patients who underwent allogeneic peripheral blood hematopoietic...
8.
Ruiz-Arguelles G, Gomez-Almaguer D, Morales-Toquero A, Gutierrez-Aguirre C, Vela-Ojeda J, Garcia-Ruiz-Esparza M, et al.
Bone Marrow Transplant
. 2005 Oct;
36(12):1043-7.
PMID: 16247424
Using a reduced-intensity stem cell transplantation (RIST) schedule, 24 patients with Philadelphia (Ph1) (+) chronic myelogenous leukemia (CML) in first chronic phase (CP) were prospectively allografted in four Latin American...
9.
Vela-Ojeda J, Garcia-Ruiz Esparza M, Reyes-Maldonado E, Jimenez-Zamudio L, Garcia-Latorre E, Moreno-Lafont M, et al.
Stem Cells Dev
. 2005 Jun;
14(3):310-6.
PMID: 15969626
We prospectively conducted a quantitative and phenotypic analysis of T, B, natural killer (NK), NKT, type 1 and 2 dendritic cells (DC), and regulatory T cells, before and after mobilization...
10.
Vela-Ojeda J, Garcia-Ruiz Esparza M, Tripp-Villanueva F, Ayala-Sanchez M, Delgado-Lamas J, Garces-Ruiz O, et al.
Stem Cells Dev
. 2004 Dec;
13(5):571-9.
PMID: 15588514
Reduced intensity conditioning (RIC) have allowed the application of transplantation to older patients and to patients with underlying medical problems. Between October, 1999, and June, 2003, 61 patients with acute...